Gapping up
In reaction to strong earnings/guidance:
- BITA +10.7%, EXPR +9.1%, VEEV +7.9%, KEYS +7.7%, SY +7%, DBI +6.2%, DG +4.5%, CSIQ +4.1%, VRNT +1.5%, SMTC +1.5%, TITN +1.1%
Other news:
- UBX +9.5% (Unity Biotechnology and UC San Francisco enter exclusive license agreement relating to alpha-Klotho protein)
- BYND +5% (after closing at new post-IPO highs)
- VIAV +2.3% (disclosed that it adopted the Company's Executive Variable Pay Plan for fiscal year 2020)
- EPZM +0.4% (submits NDA to the FDA for accelerated approval of tazemetostat for the treatment of patients with metastatic or locally advanced epithelioid sarcoma not eligible for curative surgery)
Analyst comments:
- HUYA +1.8% (initiated with Buy and $26 tgt at BofA/Merrill)